Because the degree of N-glycan branching and extent of terminal fucosylation can attenuate or enhance protein-drug interactions [26], the important part of our studies was the investigations of melanoma cell lines with (G361) and without (MeWo) BRAF mutation treated with VEM. Here, BRAF is linked to melanoma.